Cargando…
Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351922/ https://www.ncbi.nlm.nih.gov/pubmed/35935606 http://dx.doi.org/10.1097/HS9.0000000000000754 |
_version_ | 1784762537714122752 |
---|---|
author | Lenk, Lennart Winterberg, Dorothee Vogiatzi, Fotini Laqua, Anna Spory, Lea Mayar, Ahmad Dietterle, Anna Münch, Gina Vokuhl, Christian Richter, Julia Polson, Andrew G. Schüler, Thomas Kahlert, Ulf D. Peipp, Matthias Valerius, Thomas Schrappe, Martin Cario, Gunnar Jumaa, Hassan Hobeika, Elias Brüggemann, Monika Alsadeq, Ameera Schewe, Denis M. |
author_facet | Lenk, Lennart Winterberg, Dorothee Vogiatzi, Fotini Laqua, Anna Spory, Lea Mayar, Ahmad Dietterle, Anna Münch, Gina Vokuhl, Christian Richter, Julia Polson, Andrew G. Schüler, Thomas Kahlert, Ulf D. Peipp, Matthias Valerius, Thomas Schrappe, Martin Cario, Gunnar Jumaa, Hassan Hobeika, Elias Brüggemann, Monika Alsadeq, Ameera Schewe, Denis M. |
author_sort | Lenk, Lennart |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9351922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93519222022-08-05 Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia Lenk, Lennart Winterberg, Dorothee Vogiatzi, Fotini Laqua, Anna Spory, Lea Mayar, Ahmad Dietterle, Anna Münch, Gina Vokuhl, Christian Richter, Julia Polson, Andrew G. Schüler, Thomas Kahlert, Ulf D. Peipp, Matthias Valerius, Thomas Schrappe, Martin Cario, Gunnar Jumaa, Hassan Hobeika, Elias Brüggemann, Monika Alsadeq, Ameera Schewe, Denis M. Hemasphere Letter Lippincott Williams & Wilkins 2022-07-15 /pmc/articles/PMC9351922/ /pubmed/35935606 http://dx.doi.org/10.1097/HS9.0000000000000754 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter Lenk, Lennart Winterberg, Dorothee Vogiatzi, Fotini Laqua, Anna Spory, Lea Mayar, Ahmad Dietterle, Anna Münch, Gina Vokuhl, Christian Richter, Julia Polson, Andrew G. Schüler, Thomas Kahlert, Ulf D. Peipp, Matthias Valerius, Thomas Schrappe, Martin Cario, Gunnar Jumaa, Hassan Hobeika, Elias Brüggemann, Monika Alsadeq, Ameera Schewe, Denis M. Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title_full | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title_fullStr | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title_full_unstemmed | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title_short | Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia |
title_sort | preclinical evidence for the efficacy of cd79b immunotherapy in b-cell precursor acute lymphoblastic leukemia |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351922/ https://www.ncbi.nlm.nih.gov/pubmed/35935606 http://dx.doi.org/10.1097/HS9.0000000000000754 |
work_keys_str_mv | AT lenklennart preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT winterbergdorothee preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT vogiatzifotini preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT laquaanna preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT sporylea preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT mayarahmad preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT dietterleanna preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT munchgina preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT vokuhlchristian preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT richterjulia preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT polsonandrewg preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT schulerthomas preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT kahlertulfd preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT peippmatthias preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT valeriusthomas preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT schrappemartin preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT cariogunnar preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT jumaahassan preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT hobeikaelias preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT bruggemannmonika preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT alsadeqameera preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia AT schewedenism preclinicalevidencefortheefficacyofcd79bimmunotherapyinbcellprecursoracutelymphoblasticleukemia |